中材國際(600970.SH):全資子公司簽署3.515億美元的《伊拉克庫特1000MW太陽能發電項目總承包合同》
格隆匯11月19日丨中材國際(600970.SH)公佈,公司全資子公司蘇州中材建設有限公司與伊拉克
MASS 再生能源生產公司(即 MASS Iraq Co. ForRenewable Energy Production,簡稱“業主”)簽訂了《伊拉克庫特1000MW太陽能發電項目總承包合同》,合同金額3.515億美元。
該項目位於伊拉克瓦西特省庫特市,合同內容為1000MW太陽能發電項目總承包工程,包括設計、設備材料供貨、工程施工、安裝、測試和調試等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.